Multiple endocrine neoplasia type 2 laboratory findings: Difference between revisions
m (Ammu Susheela moved page Multiple endocrine neoplasia type 2 laboratory tests to Multiple endocrine neoplasia type 2 laboratory findings) |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== | ||
Laboratory findings consistent with the [[diagnosis]] of multiple endocrine neoplasia type 2 include [[hypercalcemia]], [[hypophosphatemia]], elevated [[parathyroid hormone]] and elevated [[norepinephrine]]. | Laboratory findings consistent with the [[diagnosis]] of multiple endocrine neoplasia type 2 include [[hypercalcemia]], [[hypophosphatemia]], elevated [[parathyroid hormone]], and elevated [[norepinephrine]]. | ||
==Laboratory Tests== | ==Laboratory Tests== | ||
* Some of the laboratory findings of multiple endocrine neoplasia type 2 is tabulated below. | * Some of the laboratory findings of multiple endocrine neoplasia type 2 is tabulated below. | ||
Line 62: | Line 62: | ||
| style="padding: 0 5px; background: #4479BA" colspan=3 |{{fontcolor|#FFF| Urine}} | | style="padding: 0 5px; background: #4479BA" colspan=3 |{{fontcolor|#FFF| Urine}} | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 100%; background: #f0f0f0" align=left| | ! style="padding: 0 5px; font-size: 100%; background: #f0f0f0" align=left|Epineprhine | ||
| style="padding: 0 5px; font-size: 100%; background: #f0f0f0" align=left|0.5 - 20 mcg/24 hours | | style="padding: 0 5px; font-size: 100%; background: #f0f0f0" align=left|0.5 - 20 mcg/24 hours | ||
| style="padding: 0 5px; font-size: 100%; background: #f0f0f0" align=left|>20 mcg/24 hours | | style="padding: 0 5px; font-size: 100%; background: #f0f0f0" align=left|>20 mcg/24 hours | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 100%; background: #f0f0f0" align=left| | ! style="padding: 0 5px; font-size: 100%; background: #f0f0f0" align=left|Metaneprhrine | ||
| style="padding: 0 5px; font-size: 100%; background: #f0f0f0" align=left|24 - 96 mcg/24 hours | | style="padding: 0 5px; font-size: 100%; background: #f0f0f0" align=left|24 - 96 mcg/24 hours | ||
| style="padding: 0 5px; font-size: 100%; background: #f0f0f0" align=left|> 96 mcg/24 hours | | style="padding: 0 5px; font-size: 100%; background: #f0f0f0" align=left|> 96 mcg/24 hours |
Revision as of 02:58, 5 October 2015
Multiple endocrine neoplasia type 2 Microchapters |
Differentiating Multiple endocrine neoplasia type 2 from other Diseases |
---|
Diagnosis |
Treatment |
Multiple endocrine neoplasia type 2 laboratory findings On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 laboratory findings |
FDA on Multiple endocrine neoplasia type 2 laboratory findings |
CDC on Multiple endocrine neoplasia type 2 laboratory findings |
Multiple endocrine neoplasia type 2 laboratory findings in the news |
Blogs on Multiple endocrine neoplasia type 2 laboratory findings |
Directions to Hospitals Treating Multiple endocrine neoplasia type 2 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Laboratory findings consistent with the diagnosis of multiple endocrine neoplasia type 2 include hypercalcemia, hypophosphatemia, elevated parathyroid hormone, and elevated norepinephrine.
Laboratory Tests
- Some of the laboratory findings of multiple endocrine neoplasia type 2 is tabulated below.
Test | Findings |
---|---|
Metabolic | Hypophosphatemia Hypercalcemia Elevated calcitonin Elevated epinephrine Elevated norepinephrine Elevated metanephrine Elevated vanillylmandelic acid Elevated parathyroid hormone Elevated pentagastrin |
Urinalysis | Elevated norepinephrine Elevated metanephrine Elevated vanillylmandelic acid |
Adapted from Marquard J, Eng C. Multiple Endocrine Neoplasia Type 2. 1999 Sep 27 [Updated 2015 Jun 25]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1257/[1] |
References
|